O’Melveny Practices, Lawyers Highly Ranked China in 2024 Legal 500 Greater China Guide
November 24, 2023
FOR IMMEDIATE RELEASE
HONG KONG—NOVEMBER 24, 2023—O’Melveny is recommended in multiple practice areas in Greater China in 2024 edition of The Legal 500 Greater China. In addition, a number of O’Melveny lawyers are recognized as “Hall of Fame”, “Leading Individual”, and/or “Rising Star” practitioners.
O’Melveny Legal 500 China 2024 Rankings and Mentions:
China:
- Corporate And M&A: Foreign Firms
- Private Equity: Foreign Firms
- Insurance: Foreign Firms
- Antitrust and Competition: Foreign Firms
- Life Sciences and Healthcare: Foreign Firms
Hong Kong:
- Antitrust and Competition
- Capital Markets (Equity)
- Dispute Resolution: Litigation
- Corporate (Including M&A)
Leading Individuals and Hall of Famers:
Walker Wallace
- Hall of Fame: China, Corporate And M&A: Foreign Firms
- Hall of Fame: China, Private Equity: Foreign Firms
Denis Brock
- Hall of Fame: China/Hong Kong, Dispute Resolution: Litigation
- Leading Individual: Hong Kong, Dispute Resolution: International Arbitration
- Leading Individual: China, Insurance: Foreign Firms
Philip Monaghan
- Leading Individual: Hong Kong, Antitrust and Competition
Kieran Humphrey
- Rising Star: China/Hong Kong, Dispute Resolution: Litigation
Other Highlighted Individuals:
Nima Amini
- China, Private Equity: Foreign Firms
- Hong Kong, Corporate (Including M&A)
Alan Bao
- China, Corporate And M&A: Foreign Firms
Ke Geng
- China, Corporate And M&A: Foreign Firms
- China, Life Sciences and Healthcare: Foreign Firms
- China, Private Equity: Foreign Firms
Kieran Humphrey
- Hong Kong, Insurance
Edwin Kwok
- Hong Kong, Capital Markets (Equity)
- Hong Kong, Corporate (Including M&A)
Lining Shan
- China, Antitrust and Competition: Foreign Firms
Nolan Shaw
- Hong Kong, Corporate (Including M&A)
Vivian Wang
- China, Antitrust and Competition: Foreign Firms
Ke Zhu
- Hong Kong, Capital Markets (Equity)
Commentary from Legal 500
“Practice head Ke Geng is an expert advisor on biotech and medical device IPOs, who also has direct industry knowledge through holding a biochemistry PhD.”
“Under the guidance of Edwin Kwok and Ke Zhu, the firm has gained most prominence as a result of its ability to provide ‘feasible and effective solutions’ in the context of biotech and life sciences issuances.”
“Walker Wallace’s extensive experience in international transactions sees him handling inwards Chinese investment for multinationals, as well as PE funds buying assets throughout Southeast Asia.”
“Nima Amini regularly advises on complex cross-border transactions across Asia, Europe and the US.”
“Denis Brock is highly sought after by major domestic and international clients to advise on disputes concerning investments, joint ventures and commodities.”
“Philip Monaghan combines his EU law background with his antitrust expertise in Hong Kong – he is particularly noted for his knowledge of merger control within the semiconductor industry.”
About O’Melveny
It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com; read our Insights 2023 report; hear what our lawyers, business professionals, and clients have to say in the “Our DNA” video series, learn more in our firm at-a-glance; and find us on LinkedIn, Twitter, Facebook, Instagram, and YouTube.
Contact:
Brandon Jacobsen
O’Melveny & Myers LLP
+1 213 430 8024
bjacobsen@omm.com
Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com
# # #